Guide your regulatory strategy
Pink Sheet provides you with keen analysis on news and regulatory trends to help you effortlessly navigate biopharma policy and inform your regulatory strategies. Gain insights that can propel your products to market success.
Download key articles from our expert journalists
Our expert journalists at Pink Sheet have selected free article packs to help you gain incisive analysis of current and future policy trends to help inform your regulatory strategies.
Article pack 1: Trump's International Pricing Plan
President Trump's second attempt to get the US to adopt Most Favored Nation pricing is already off to a stronger start than the efforts that were quashed in court at the end of his first term. The situation offers some promise but mostly peril for the pharma indistry, especially as the US FDA may be activated as never before to press an explicit pricing agenda. The Pink Sheet's globe-spanning staff offers reports of happenings in European capitals and the White House to help industry predict what might come next.
Article pack 2: Clinical Trial Reform in the United Kingdom
The disruptive energy coming out of the White House has also activated UK regulators as they think about how to reform their clinical trail system. And while the topic flies under the radar compared to attention-grabbing issues like price setting and tariffs, streamlining the clinical stage can have a profound impact on company's bottom line and a region's industrial ecosystem.
What is Pink Sheet?
Since 1939, Citeline’s Pink Sheet has been the leader in providing business-critical insights on pharmaceutical news, and analysis of regulatory policies and trends. Our global team of over 60 journalists track product progress from submission to approval, covering all industry sectors: biosimilars, generics, OTC drugs, and more.
Hear our Pink Sheet journalists from across the globe discuss the important implications of complex biopharma regulations and identify emerging policy directions to help you navigate the every-changing regulatory standards.